Compugen (CGEN) Reports Q3 Loss of $0.07/sh

Compugen (NASDAQ: CGEN) reported Q3 EPS of ($0.07), versus ($0.09) reported last year. Revenue for the quarter came in at $6 million, versus $0 reported last year.

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
• JPMorgan Downgrades Anima Holding SA (ANIM3:BZ) to Neutral
• Pfizer reaffirms 2026 guidance after CFO transition news